Verum GI has discovered several novel biomarkers in the gastrointestinal area. We are developing simple, accurate & rapid tests with applications for the detection & prediction of appendicitis, upper & lower GI bleeding, & small intestinal & stomach cancer.
AppendiSURE, our simple, affordable, clinically-effective appendicitis screening test gets proven results in minutes at the point of care. For the first time, health professionals will have a reliable tool to save lives in physical crisis and promote patient health and healing.
AppendiSure is currently being developed in a laboratory test format with 324 clinical samples. The current format AppendiSURE test detects appendicitis in a blood sample by using a specific monoclonal antibody raised to detect a unique biomarker. This biomarker has been found only in the blood of patients diagnosed with Appendicitis and is absent in patients who do not have appendicitis.
Company’s Keywords:
duodenal cancer, diagnostics, biomarkers, point of care, peptic ulcer, appendicitis, gastrointestinal, gastric bleeding, gastric cancer, duodenal bleeding
<2
<
<
Your request has been submitted successfully.
Own or work here?